Veröffentlichungen

  • Intramedullary placement of intraosseous cannulas inserted in the preclinical treatment of polytrauma patients: A retrospective, computed tomography-assisted evaluation. Jansen G, Leimkühler K, Mertzlufft F: Anaesthesist 2017; 66: 168 - 176.

  • Characteristics and provision of care of patients with the acute respiratory distress syndrome: descriptive findings from the DACAPO cohort baseline and comparison with international findings. Dodoo-Schittko F, Brandstetter S, Brandl M, Blecha S, Quintel M, Weber-Carstens S, Kluge S, Meybohm P, Rolfes C, Ellger B, Bach F, Welte T, Muders T, Thomann-Hackner K, Bein T, Apfelbacher C. J Thorac Dis 2017; 9: 818 - 830.

  • Mycobacterium marinum antagonistically induces an autophagic response while repressing the autophagic flux in a TORC1- and ESX-1-dependent manner. Cardenal-Muñoz E, Arafah S, López-Jiménez AT, Kicka S, Falaise A, Bach F, Schaad O, King JS, Hagedorn M, Soldati T. PLoS Pathog 2017; 13: e1006344.

  • Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Bloos F, Rüddel H, Thomas-Rüddel D, Schwarzkopf D, Pausch C, Harbarth S, Schreiber T, Gründling M, Marshall J, Simon P, Levy MM, Weiss M, Weyland A, Gerlach H, Schürholz T, Engel C, Matthäus-Krämer C, Scheer C, Bach F, Riessen R, Poidinger B, Dey K, Weiler N, Meier-Hellmann A, Häberle HH, Wöbker G, Kaisers UX, Reinhart K; MEDUSA study group. Intensive Care Med 2017. doi: 10.1007/s00134-017-4782-4. [Epub ahead of print].

  • Metamizole for postoperative pain therapy in infants younger than 1 year. Sümpelmann R, Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Dennhardt N. Eur J Pediatr Surg 2017; 27: 269 – 273.

  • CHAOS in neonatal emergency care? Tracheal agenesis in the obstetric theatre. Jansen G, Schmidt B, Mertzlufft F, Boesing T, Barthel M. Anaesthesist 2016; 65: 763 – 767.

  • Isadora-Duncan-Syndrom - Letale Strangulationsverletzung an einer Getränkeabfüllmaschine. Jansen G, Mertzlufft F. Anaesthesist 2016; 65: 359–362.

  • Präklinische Routine? Ein besonderer Fall von akutem Koronarsyndrom. Jansen G, Mertzlufft F, Bach F. Notfall Rettungsmed 2016; 19: 279 – 282.

  • Posterior disconnection surgery in a patient with Lennox-Gastaut syndrome and transitory deficiency of factor VII and protein C. Leimkühler K, Cloppenborg T, Kalbhenn T, Schmidt B, Polster T, Mertzlufft F. Hämostaseologie 2016; 36 (Suppl. 1): 43.

  • Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results fom the GTH-AH 01/2010 study. Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, Gottstein S, Geisen U, Schenk J, Scholz U, Schilling K, Neumeister P, Miesbach W, Manner D, Greil R, von Auer C, Krause M, Leimkühler K, Kalus U, Blumtritt JM, Wer­witzke S, Budde E, Koch A, Knöbl P. Blood 2015; 125: 1091 - 1097.

  • Reversibles zerebrales Vasokonstriktionssyndrom. Jansen G, Mertzlufft F, Bach F. Anaesthesist 2015; 64: 574 – 579.

  • Metamizole for postoperative pain therapy in 1177 children: A prospective, multicentre, observational, postauthorisation safety study. Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Messroghli L, Boethig D, Sümpelmann R. Eur J Anaesthesiol 2015; 32: 839 – 843.

  • Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock.Thomas-Rueddel DO, Poidinger B, Weiss M, Bach F, Dey K, Häberle H, Kaisers U, Rüddel H, Schädler D, Scheer C, Schreiber T, Schürholz T, Simon P, Sommerer A, Schwarzkopf D, Weyland A, Wöbker G, Reinhart K, Bloos F; Medical Education for Sepsis Source Control and Antibiotics Study Group. J Crit Care 2015. 30: 439.e1-6. doi: 10.1016/j.jcrc.2014.10.027.

  • Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera Groba C, Leone M, Vincent JL; EPIC II Investigators; Margarit A, Valentini RBach F, Bui T, Potie F, Huu CN. BMC Infect Dis 2014; 14: 420. doi: 10.1186/1471-2334-14-420.

  • Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study. Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos C, Taccone FS, Sevcik P, Moreno C, Vincent JL; EPIC II Group of Investigators; Margarit A, Valentini RBach F … Bui T, Potie F, Nguyen Huu C. Liver Int 2014; 34:1496 - 1503.

  • Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Bloos F, Thomas-Rüddel D, Rüddel H, Engel C, Schwarzkopf D, Marshall JC, Harbarth S, Simon P, Riessen R, Keh D, Dey K, Weiß M, Toussaint S, Schädler D, Weyland A, Ragaller M, Schwarzkopf K, Eiche J, Kuhnle G, Hoyer H, Hartog C, Kaisers U, Reinhart K; MEDUSA Study Group; Marx G, Schürholz TBach F, Bachmann-Holdau U, Eiche J, Lange M. Crit Care 2014; 18: R42 (1 – 10).

  • Traumatic dissection of the carotid artery: Challenges for diagnostics and therapy illustrated by a case example. Jansen G, Popp J, Dietrich U, Mertzlufft F, Bach F. Anaesthesist 2013; 62: 817 -823.

  • Cardiac arrest and hypothermia caused by suicidal intoxication with Butane. Jansen G, Mertzlufft F, Kirchhoff C, Bach F. Notarzt 2013; 29: 15 – 22.

  • The Role of intercostal nerve preservation in pain control after thoracotomy. Koop O, Gries A, Eckert S, Ellermeier S, Hoksch B, Branscheid D, Beshay M. Eur J Cardiothorac Surg 2012; 40: 1-5.

  • Effect of empirical treatment with Moxifloxacin and Meropenem vs Meropenem on sepsis-re­la­ted organ dysfunction in patients with severe sepsis - A randomized trial. Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, Ja­schinski U, Meier-Hellmann A, Weyland A, Gründling M, Moerer O, Riessen R, Seibel A, Ragaller M, Büchler MW, John S, Bach F, Spies C, Reill L, Fritz H, Kiehntopf M, Kuhnt E, Bogatsch H, Engel C, Loeffler M, Kollef MH, Reinhart K, Welte T. JAMA 2012; 307: 2390 - 2399.

  • Reanimation unter Hypothermie nach suizidaler Butangasintoxikation. Jansen G, Mertzlufft F, Kirchhoff C, Bach F. Anästhesiol Intensivmed Notfallmed Schmerzther 2012; 47: 78 – 85.

  • HES-Koordinaten 2011. Mertzlufft F. Makro-Mikrozirkulation 2011; 39: 1 – 8.

  • Candida bloodstream infections in in­tensive care units: analysis of the extended prevalence of infection in intensive ca­re unit study. Kett DH, Azoulay E, Echeverria PM, Vincent JL, Extended Prevalence of Infection in ICU Study. EPIC II Group of Investigators; Margarit A, Valentini R ... Bach F, Sakr Y, Potie F, Ngu­yen Huu C. Crit Care Med 2011; 39: 665 - 670.

  • Abführmaßnahmen in der Intensivmedizin. Bach F; in: Praxis der Intensivmedizin. Wilhelm W (Hrsg.), Springer, Heidelberg, 2011, S. 132 – 141.

  • Monitoring und Katheter. Wilhelm W, Larsen R, Pargger H, Ziegeler S, Mertzlufft F; in: Klinikmanual Intensivmedizin. Burchardi H, Larsen R, Marx G, Muhl E, Schölmerich J (Hrsg.),  Springer, Heidelberg, 2011, S. 24 – 40.

  • Die knappe Ressource Notarzt: Abgrenzung eines notärztlichen von einem nicht-notärztlichen Einsatz. Meyer V, Mertzlufft F, Weber T. Rettungsdienst 2011; 34: 34 – 39.

  • Acquired von Willebrand's disease type 2A following arte­rio­ve­nous fistula for haemodialysis? Leimkühler K, Bach F, Kuhlmann S, Feidicker B, Heim MU, Susemihl C, Mertzlufft F. Hämostaseologie 2011; 31: 1 – 5.

  • Intensivmedizin zwischen Behandlungsauftrag und Be­hand­lungsbegrenzung. Heesch E, Bach F, Kobert K, Mertzlufft F; in: Intensivmedizin. Eckart J, Forst H, Briegel J (Hrsg.), Ecomed Medizin, Lands­berg, 2011, S. 1 – 11.

  • Dealing with (no longer) needed narcotics in the outpatient pal­liative care setting. Thöns M, Flender HJ, Mertzlufft F, Zenz M. Schmerz 2010; 24: 367 – 372.

  • Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: re­sults of a phase II multicenter, randomized, pla­ce­bo-controlled, dose-finding clinical trial. Dellinger RP, Tomayko JF, Angus DC, Opal S, Cupo MA, McDermott S, Ducher A, Calandra T, Cohen J, Lipid Infusion and Patient Outcomes in Sepsis (LIPOS) Investigators; Blejman S, Cahn P, Conforti A ... Mertzlufft F, Quaranta A, Le­Doux E, Tural A. Crit Care Med 2009; 37: 2929 -2938.

  • Autologous blood donor screening indicated a lower pre­va­len­ce of viral hepatitis in East vs West Germany: epidemiological benefit from established health re­sou­r­ces. Wiegand J, Luz B, Mengelkamp AK, Moog R, Koscielny J, Halm-Heinrich I, Susemihl C, Bentzien F, Diekmann J, Wernet D, Karger R, Angert K, Schmitt-Thomssen A, Kiefel V, Lutter K, Hesse R, Kätzel R, Opitz A, Luhm J, Barz D, Leib U, Matthes G, Tillmann HL. J Viral Hepat 2009; 16: 743 - 748. 

  • Intensivmedizin: Zwischen Behandlungsauftrag und -Begrenzung. Heesch E, Bach F, Kobert K, Mertzlufft F. J An Ints 2009; 4: 16 – 24.

  • Effect of whole-body CT during trauma resuscitation on survival: a retrospective, multicentre stu­dy. Huber-Wagner S, Lefering R, Qvick LM, Körner M, Kay MV, Pfeifer KJ, Reiser M, Mutschler W, Kanz KG; Working Group on Polytrauma of the German Trauma So­ciety: Lancet 2009; 373 (9673): 1455 – 61.

  • Routine use of nasogastric tubes does not reduce postoperative nausea and vomiting. Kerger KH, Mascha E, Steinbrecher B, Frietsch T, Radke OC, Stoecklein K, Frenkel C, Fritz G, Danner K, Turan A, Apfel CC, IMPACT Investigators; Apfel CC, Biedler A, Korttila K … Mertzlufft F, Werthwein K, Wilhelm W, Zernak C. Anesth Analg 2009; 109: 768 – 773.

  • Der Einfluß von Temperatur und Säure-Basen-Status auf die Gerinnung bzw. Fi­bri­nolyse muß bei der Diagnostik berücksichtigt werden. Zander R, Mertzlufft F. QualiTest 2009; 11: 1 - 6. 

  • Volu­me cau­ses pressure. Mertzlufft F, Schaffartzik W. Anaesthesist 2009; 58: 391.

  • Behandlungsauftrag und Behandlungs­be­gren­zung: eine Klinisch-Ethische Kasuistik. Heesch E, Bach F, Kobert K, Mertzlufft F. Plexus 2009; 17: 6 – 15.

  • Clinical possibilities for controlling body temperature. Bach F, Mertzlufft F. Anaesthesist 2007; 56: 917 – 922. 

  • The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT. Koster A, Fischer KG, Harder S, Mertzlufft F. Biologics 2007; 1: 105 - 112.

  • Bach F, Mertzlufft F: Therapeutic hypothermia and acid-base management. Anaesthesist 2007; 56: 366 – 370.

  • The design of the VISEP trial. Critical appraisal. Zander R, Boldt J, Engelmann L, Mertzlufft F, Sirtl C, Stuttmann R. Anaesthesist 2007; 56: 71 – 77.

  • Volume causes pressure. Mertzlufft F. Anaesthesist 2007; 56: 1 – 3.

  • Hämodynamisches und respi­ra­to­risches Monitoring. Wilhelm W, Larsen R, Pargger H, Mertzlufft F, Bach F; in: Die Intensivmedizin. Burchardi H, Larsen R, Kuhlen R, Jauch KW, Schölmerich J (Hrsg), 10. Aufl., Springer, Heidelberg, 2007, 131 ff.

  • Dedication to Rolf Zander. Mertzlufft F. Anaesthesist 2007; Mar 3 [Epub].

  • Analgesierungs- und Sedierungsmaßnahmen. Bach F, Eckert S, Mertzlufft F; in: Facharztprüfung Chir­ur­gie. Reymond MA, Lippert H, Haas NP (Hrsg.), 2. Aufl., Urban & Fischer, 2007, 92 ff.

  • Perioperative Volumentherapie, Hämotherapie, Hämostaseologie. Leimkühler K, Mertzlufft F, Bach F; in: Fach­arztprüfung Chirurgie. Reymond MA, Lippert H, Haas NP (Hrsg.), 2. Aufl., Urban & Fischer, 2007, 154 ff.

  • Akute Notfälle. Eckert S, Bach F, Mertzlufft F; in: Fach­arzt­prü­fung Chirurgie. Reymond MA, Lippert H, Haas NP (Hrsg.), 2. Aufl., Urban & Fischer, 2007, 169 ff.

  • Laborchemisches Monitoring. Mertzlufft F, Jantos C, Bach F, Gatzounis G, Koster A; in: In­ten­siv­medizin. van Aken H, Reinhart K, Zimpfer M, Welte T (Hrsg.), Thieme, Stutt­gart – New York, 2. Aufl. 2007, 357 ff.

  • Therapie eines schweren ARDS bei einem Schädel-Hirn-trau­matisiertem Patienten. Bach F, Borgstedt R, Grünzig R, Mertzlufft F. Intensivmed 2006; 43 (Suppl 1): 8 – 9.

  • Steuerung der Körpertemperatur in Notfall- und Intensivmedizin. Bach F, Mertzlufft F. Mana­ge­ment und Kran­kenhaus 2006; 11: 12 – 13.

  • Sepsis – an ever new challenge. Bach F, Bause H, Kaisers U, Mertzlufft F. Anaes­the­si­ol Inten­sivmed Not­fallmed Schmerzther 2006; 41: 27 – 31.

  • Patientennahe Sofortdiagnostik. Zander R, Schaffartzik W, Mertzlufft F. QualiTest 2005; 8: 2 – 7. 

  • Opti­mi­zing the oxy­gen supply. Roewer N, Krier C, Nöldge-Schomburg, Mertzlufft F, Bach F, Schaffartzik W. Anästhesiol In­ten­siv­med Notfallmed Schmerz­ther 2005; 40: 592 – 593.

  • The optimization of oxygen levels. Mertzlufft F, Bach F, Schaffartzik W. Anästhesiol In­ten­siv­med Not­fallmed Schmerzther 2005; 40: 593 - 597.

  • Pathophysiologie und Überwachung des pulmonalen Gas­aus­tauschs. Mertzlufft F, Bach F, Kulbe C; in: Hand­buch der Kinderintensivmedizin. Brömme W, Lietz R, Bennek J (Hrsg.), Thie­me, Stuttgart, 2. Aufl., 2005, 133 – 141.

  • A fac­to­ri­al trial of six interventions for the prevention of postoperative nausea and vomiting. Apfel CC, Ba­cher A, Biedler A, Danner K, Danzeisen O, Eberhart LH, Forst H, Fritz G, Hergert M, Frings G, Goebel A, Hopf HB, Kerger H, Kranke P, Lange M, Mertzlufft F, Motsch J, Paura A, Roewer N, Schneider E, Stoecklein K, Wermelt J, Zernak C. An­aesthesist 2005; 54: 201 – 209.

  • Dietrich U, Maas S, Bach F: Aneurysm of the petrous part of the A. carotis interna with recurrent life-threatening epistaxis. Rofo 2005; 177: 137 – 138.

  • A factorial trial of six in­ter­ven­tions for the prevention of postoperative nausea and vomiting. Apfel CC, Kor­t­tila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kre­del M, Biedler A, Sessler DI, Roewer N, IMPACT Investigators; Apfel CC, Korttila K, Biedler A … Mertzlufft F … Sneyd R, Koschel U, Lange M. N Engl J Med 2004; 350: 2441 – 2451.

  • Pflegeversicherungsgesetz. Klein M, Hankemeier U; in: Tumorschmerztherapie. Hankemeier U, Krizanits F, Schüle-Hein K (Hrsg.), 3. Aufl., Springer, 2004, S. 399 – 404.

  • Psychoonkologie. Richter W, Isselstein-Mohr D, Krizanits F; in: Tumorschmerztherapie. Hankemeier U, Krizanits F, Schüle-Hein K (Hrsg.), 3. Aufl., Springer, 2004, S. 278 – 292.

  • Psychische Grundlagen von Schmerzempfindung, -äußerung und –behandlung. Richter W, Aulbert E, Hankemeier U; in: Tumorschmerztherapie. Hankemeier U, Krizanits F, Schüle-Hein K (Hrsg.), 3. Aufl., Springer, 2004, S. 18 – 25.

  • Accuracy of portable quan­titative capnometers and capnographs under prehospital conditions. Biedler A, Wilhelm W, Kreuer S, Soltesz S, Bach F, Mertzlufft F, Molter GP. Am J Emerg Med 2003; 21: 520 – 524.

  • Acquired he­mo­philia A as a cause of postoperative bleeding. Leimkühler K, Bach F, Kobert K, Korth M, Schmidt B, Kulbe C, Gummelt I, Mertzlufft F. Anästhesiol Intensivmed Notfallmed Schmerzther 2003; 38: 359 – 365.

  • On the pro­phy­lac­tic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced throm­bo­cy­to­pe­nia. Schenk JF, Pindur G, Stephan B, Mörsdorf S, Mertzlufft F, Kroll H, Wenzel E, Seyfert UT. Clin Appl Thromb Hemost 2003; 9: 25 – 32.

  • Assessing errors in the determination of base excess. Mentel A, Bach F, Schüler J, Herrmann W, Koster A, Crystal GJ, Gatzounis G, Mertzlufft F. Anesth Analg 2002; 94: 1141 – 1148.

  • Heparin-induced type II thrombocytopenia in intensive care. Koster A, Meyer O, Kukucka M, Mertzlufft F, Kuppe H. Wien Klin Wochenschr 2001; 113 (Suppl 1): 14 – 18.

  • Heparin-induced thrombocytopenia (HIT)—problems and their significance for ENT medicine. Kleinschmidt S, Mertzlufft F, Bach F, Plinkert PK. HNO 2001; 49: 854 – 864.

  • Anticoagulation during cardiopulmonary bypass in patients with heparin–induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb/IIIa antagonist tirofiban. Koster A, Kukucka M, Bach F, Meyer O, Fischer T, Mertzlufft F, Loebe M, Hetzer R, Kuppe H. An­es­the­si­ology 2001; 94: 245 – 251.

  • Heparin antibodies and thromboembolism in heparin-coated and non-coated ventricular assist de­vi­ces. Koster A, Loebe M, Sodian R, Potapov EV, Hansen R, Müller J, Mertzlufft F, Crystal GJ, Kuppe H, Het­zer R. J Tho­rac Cardiovasc Surg 2001; 121: 331 – 335.

  • Preoxygenation – a must! But which is the best technique to use? Mertzlufft F, Krier C. Anästhesiol Intensivmed Notfallmed Schmerzther 2001; 36: 451 – 453.

  • Monitoring bei der Atemwegssicherung. Mertzlufft F, Koster A, Bach F; in: Airway-Management. Krier C, Ge­or­gi H (Hrsg.), Thieme, 2001, 56 ff.

  • Präoxygenierung. Mertzlufft F, Koster A; in: AIRWAY-MANAGEMENT. Krier C, Georgi H. (Hrsg.), Thie­me, Stuttgart, 2001, 242 ff.

  • In vitro cross–reactivity of danaparoid sodium in patients with heparin–induced thrombocytopenia type II undergoing cardiovascular surgery. Koster A, Kuppe H, Mertzlufft F. J Clin Anesth 2000; 12: 324 – 327.

  • Pre­va­lence and persistence of he­pa­rin/platelet factor 4 antibodies in patients with heparin–coated and non hepa­rin–coated ventricular assist devices. Koster A, Sänger S, Hansen R, Sodian R, Mertzlufft F, Harke C, Kuppe H, Hetzer R, Loebe M. ASAIO J 2000; 46: 319 – 322.

  • A quick assay for monitoring r-hirudin during cardi­opulmonary bypass in patients with heparin–induced thrombocytopenia type II: Adaptation of the ecarin clotting time to the ACT II device. Koster A, Loebe M, Hansen R, Bauer M, Mertzlufft F, Kuppe H, Hetzer R. J Thorac Cardiovasc Surg 2000; 119: 1278 – 1283.

  • Elimination of r-hi­rudin by modified ultrafiltration during simulated cardiopulmonary by­pass: as­sess­ment of different filter sy­stems. Koster A, Merkle F, Hansen R, Loebe M, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. Anesth Analg 2000; 91: 265 – 269.

  • Hirudin monitoring using the TAS ecarin clotting time in patients with heparin–induced thrombocytopenia type II. Koster A, Hansen R, Grauhahn O, Hausmann H, Bauer M, Hetzer R, Kuppe H, Mertzlufft F. J Cardiothorac Vasc Anesth 2000; 14: 249 – 252.

  • Reliability of the heparin ma­nagement test (HMT) for assessing adequacy of  heparin concentration: in vi­­tro findings in volunteers vs. in vivo findings during cardiopulmonary bypass. Mertzlufft F, Koster A, Hansen R, Risch A, Kuppe H, Kübel B, Crystal GJ. Anes­the­si­o­lo­gy 2000; 92: 1594 – 1602.

  • Recombinant hirudin as an al­ter­native for anti­co­a­gu­lation during cardiopulmonary bypass in patients with heparin–induced thrombocytopenia type II: a 1–year experience in 57 patients. Koster A, Hansen R, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. J Cardiothorac Vasc Anesth 2000; 14: 243 – 248.

  • Remifentanil and propofol without muscle relaxants or with different doses of rocuronium for tracheal intubation in outpatient anaesthesia. Schlaich N, Mertzlufft F, Soltèsz S, Fuchs–Buder T. Acta Anaesthesiol Scand 2000; 44: 720 – 726.

  • In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery. Koster A, Meyer O, Hausmann H, Kuppe H, Hetzer R, Mertzlufft F. J Clin Anesth 2000; 12: 324 – 327.

  • Acute heparin–induced thrombocytopenia type II during car­diopulmonary bypass. Koster A, Crystal GJ, Kuppe H, Mertzlufft F. J Cardiothorac Vasc Anesth 2000; 14: 300 – 303.

  • Cardiovascular surgery without cardio­pul­monary bypass in pa­tients with heparin–induced thrombocytopenia type II using an­ti­coa­gulation with recombinant hirudin. Koster A, Kuppe H, Crystal GJ, Mertzlufft F. Anesth Analg 2000; 90: 292 – 298. 

  • A quick anti–Xa activity–based whole blood coa­gu­la­ti­on assay for monitoring unfractionated heparin during cardiopulmonary bypass. Hansen R, Koster A, Kukucka M, Mertzlufft F, Kuppe H. Anesth Analg 2000; 91: 533 – 538.

  • Fechtner´s sy­ndrome: Considerations of ane­sthetic management. Mertzlufft F, Koster A, Steinhart H, Schenk JF, Crystal GJ. Anesth Analg 2000; 90: 1372 – 1375.

  • Management of urgent high–risk cardiopulmonary by­pass in patients with heparin–induced thrombocytopenia type II and coexisting disorders of renal func­tion: use of hepa­rin and epoprostenol combined with on–line monitoring of platelet func­tion. Mertzlufft F, Kuppe H, Koster A. J Cardiothorac Vasc Anesth 2000; 14: 304 – 308.

  • Reliability of the heparin management test for monitoring high levels of unfractionated heparin: in vitro findings in volunteers versus in vivo findings during cardiopulmonary bypass. Mertzlufft F, Koster A, Hansen R, Risch A, Kuppe H, Kübel B, Crystal GJ. Anesthesiology 2000; 92: 1594 – 1602.

  • Auswirkung präanalytischer Fehler bei der Bestim­mung des arteriellen Sauerstoffpartial­drucks auf Größe und Aussagekraft der AaDO2. Risch A, Biedler A, Mertzlufft F: Anaesthesist 2000; 49: 29 – 33

  • Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitpr tirofiban as anticoagulant. Koster A, Loebe M, Mertzlufft F, Kuppe H, Hetzer R. Ann Thoracic Surg 2000; 70: 2160 – 2161.

  • Upper airway collapsibility in habitual snorers and sleep apneics: evaluation with drug-induced sleep endoscopy. Steinhart H, Kuhn-Lohmann J, Gewalt K, Constantinidis J, Mertzlufft F, Iro H. Acta Otolaryngol 2000; 120: 990 – 994.

  • Anästhesie und uteroplazentare Durchblutung. Wilhelm W, Berg K, Mertzlufft F; in: THEMENBUCH GE­BURTSHILFLICHE ANÄSTHESIE. Kretz FJ, Merk­le E (Hrsg.), Springer, Berlin, 2000.

  • The cricoid pressure maneuver: Child of two fathers? Mertzlufft F, Koster A. ASA Newsletter 2000; 64: 34 – 35.